Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
Australia Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: As the Australian government continues to focus on cost containment while at the same time increasing the population's access to innovative medicines, companies will increasingly need to justify the price of their treatments by ...
Apr 2016 $ 1295
Zambia Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: Real GDP growth in Zambia will remain subdued in 2016 at 3.4% due to a struggling copper industry and persistent power shortages. Private consumption will be restrained by higher interest rates and food costs stemming from a wea...
Apr 2016 $ 1295
United Kingdom Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: Although we retain our view that the UK will remain a member of the European Union after the Brexit referendum to be held on June 23, uncertainty over the outcome increased in the first months of 2016, and a Brexit would pose si...
Apr 2016 $ 1295
Qatar Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: Qatar's pharmaceuticals and healthcare sectors will continue to grow despite challenges facing the government's revenue streams. Both an increase in public spending on health, including in infrastructure projects, and the rising...
Apr 2016 $ 1295
Israel Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: Our growth outlook for Israel's pharmaceutical sector is underpinned by the government package to systematically bolster the public health system through targeted investment in health resources and infrastructure. Concerted effo...
Apr 2016 $ 1295
Iran Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: With sanctions lifted, Iran has improving prospects of opening up to a wider diversity of trading partners and providing strategic opportunities for multinational pharmaceutical companies. By reintegrating into the financial tra...
Apr 2016 $ 1295
El Salvador Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: El Salvador's pharmaceutical market will remain unattractive in the years ahead. While the government's commitment to healthcare in El Salvador will continue to improve the national healthcare system and increase patients' acces...
Apr 2016 $ 1295
Angola Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Like other oil-dependent countries, Angola has suffered from the large fall in the price of oil. The healthcare sector has been impacted by large budget cuts as a result of the lower government revenues. With waste collection se...
Apr 2016 $ 1295
Algeria Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: The Algerian pharmaceutical market will remain attractive to multinational drugmakers, despite the slow pace of improvements in the regulatory and market access environment. Key market drivers such as growing demand for healthca...
Apr 2016 $ 1295
Prescription Drugs Industry Forecasts - China Focus
By AMID
This study focuses on China's Prescription Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have trans...
Apr 2016 $ 1000
Energy Supplements Industry Forecasts - China Focus
By AMID
This study focuses on China's Energy Supplements industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have trans...
Apr 2016 $ 1000
Cephalosporin Industry Forecasts - China Focus
By AMID
This study focuses on China's Cephalosporin industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transforme...
Apr 2016 $ 1000
Penicillin Industry Forecasts - China Focus
By AMID
This study focuses on China's Penicillin industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed C...
Apr 2016 $ 1000
Diagnostic Reagent Industry Forecasts - China Focus
By AMID
This study focuses on China's Diagnostic Reagent industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have trans...
Apr 2016 $ 1000
Guatemala Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: The commercial incentives for foreign drugmakers to further expand in Guatemala's pharmaceutical market are limited by the country's low per capita pharmaceutical spending and subdued market growth. However, in spite of this, th...
Apr 2016 $ 1295
Nicaragua Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: Access to affordable medicine will continue to be challenging for the majority of Nicaraguans in the coming years. Limited healthcare funding, low per capita pharmaceutical expenditure, a small and unregulated drug market and th...
Apr 2016 $ 1295
Panama Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: Panama's decision to move forward with the unification of its public healthcare system will have a significant positive impact on the improvement of medical services in the country over the long term. The planned operational enh...
Apr 2016 $ 1295
Peru Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: In spite of its small market size and developing health care system, its promising economic outlook and its government's commitment to increased investment in the healthcare sector will be factors contributing to the improvement...
Apr 2016 $ 1295
Puerto Rico Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: Despite short-term headwinds due to fiscal tightening, Puerto Rico's pharmaceutical market is expected to observe modest positive growth over the next five years. This slightly improved outlook already represents a recovery tren...
Apr 2016 $ 1295
South Korea Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: South Korea will remain an important market for innovative pharmaceutical firms in the Asia Pacific. While the country's designation as a 'Watch List' country in PhRMA's 2016 submission highlights concerns over the regulatory en...
Apr 2016 $ 1295
United Arab Emirates Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: The sixth initiative of the UAE's medicine price reduction process will not significantly affect the country's pharmaceutical market. For drugmakers in the region, lower profit margins will be offset by increasing sales volumes....
Apr 2016 $ 1295
Vietnam Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: Vietnam's disease profile will be increasingly attractive for prescription drugmakers as chronic conditions become more prevalent. To adequately meet this large unmet medical need, pharmaceutical firms will have to adapt their p...
Apr 2016 $ 1295
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: Zimbabwe's health sector will deteriorate over the short term as a result of significant cuts to national budget allocations. Despite the distribution to healthcare growing over the last seven years, it remains far from meeting ...
Apr 2016 $ 1295
Colombia Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: A growing burden of chronic diseases, along with the Colombian government's push toward improving health coverage, will ensure the country's retained appeal to multinational drugmakers and healthcare suppliers. However, ineffici...
Apr 2016 $ 1295
Hong Kong Pharmaceuticals and Healthcare Report Q2 2016
By Business Monitor International
BMI View: The ageing of Hong Kong's demography will necessitate changes to its healthcare system. Top of the agenda will be healthcare financing, as authorities face rising medical costs as chronic diseases rise and tax revenues decline d...
Apr 2016 $ 1295